Beta lactam compounds and their use as inhibitors of tryptase

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S210150, C540S200000, C540S354000, C540S355000, C540S359000, C540S362000

Reexamination Certificate

active

06335324

ABSTRACT:

BACKGROUND OF THE INVENTION
Han in U.S. Pat. Nos. 5,037,819, 5,110,812, 5,175,283, 5,250,677 and 5,326,863 discloses 3-guanidinoalkyl-2-azetidinones of the formula:
wherein:
U and W are independently selected from hydrogen and amino protecting groups;
n is an integer from 1 to 3;
X is hydrogen, trialkylsilyl, arylsulfonyl, amino substituted arylsulfonyl, alkylsulfonyl, arylaminocarbonyl, alkylcarbonyl or arylcarbonyl;
Y is hydrogen, arylalkenyl, arylalkyl, formyl, carboxy, alkoxycarbonyl, acyloxy, arylthio, arylsulfinyl, arylsulfonyl, alkythio, alkylsulfinyl, alkylsulfonyl, arylaminocarbonyl,
 R is hydrogen, alkyl, or arylalkyl;
m is an integer from 1 to 3; and
R′, is hydrogen or —CO
2
R″ wherein R″ is hydrogen, alkyl, or arylalkyl.
Han further discloses that the above compounds wherein:
U and W are hydrogen;
X is arylsulfonyl, amino substituted arylsulfonyl, alkylsulfonyl, arylaminocarbonyl, alkylcarbonyl, or arylcarbonyl; and
Y is hydrogen, arylalkyl, carboxy, alkoxycarbonyl, acyloxy, arylsulfonyl, alkylthio, alkylsulfonyl, arylaminocarbonyl,
 R is hydrogen, alkyl or arylalkyl;
R′, is hydrogen or —CO
2
R″;
R″, is hydrogen, alkyl, or arylalkyl and pharmaceutically acceptable salts thereof are inhibitors against serine proteases, particularly against thrombin and trypsin, and can be used to control blood coagulation or to treat pancreatitis.
Han defines “aryl” as a phenyl or naphthyl group which may be unsubstituted or substituted with one or more groups such as amino, nitro, or alkyl and defines “amino” as unsubstituted or substituted with one or two alkyl radicals.
SUMMARY OF THE INVENTION
This invention is directed to the novel beta lactam compounds of formulas I, II, III, IV, and V shown below and to the use of such compounds as inhibitors of various in vivo enzyme systems including tryptase, thrombin, trypsin, Factor Xa, Factor VIIa, and urokinase-type plasminogen activator. This invention is also directed to the use of the compounds of formula VI shown below as tryptase, Factor Xa, Factor VIIa, and urokinase-type plasminogen activator inhibitors.
Compounds of this invention include the formula:
wherein:
R
1
is hydrogen, carboxy, alkoxycarbonyl, A
2
-aryl,
or R
1
is alkyl provided that R
2
is alkyl and R
3
is hydrogen.
R
2
and R
3
are both hydrogen, or R
2
is alkyl provided that R
3
is hydrogen, or R
3
is alkyl provided that R
2
is hydrogen.
R
4
and R
5
are independently selected from hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, A
2
-cycloalkyl, A
2
-substituted cycloalkyl, aryl, substituted aryl, A
2
-aryl, A
2
-substituted aryl, heteroaryl, A
2
-heteroaryl, heterocycloalkyl, A
2
-heterocycloalkyl, aryl-A
3
-aryl, A
2
-aryl-A
3
-aryl, aryl-A
3
-cycloalkyl, A
2
-aryl-A
3
-cycloalkyl, aryl-A
3
-heteroaryl, A
2
-aryl-A
3
-heteroaryl, aryl-A
3
-heterocycloalkyl, A
2
-aryl-A
3
-heterocycloalkyl, aryl-A
3
-substituted aryl, A
2
-aryl-A
3
-substitued aryl, aryl-A
3
-substituted cycloalkyl, A
2
-aryl-A
3
-substituted cycloalkyl, cycloalkyl-A
3
-cycloalkyl, A
2
-cycloalkyl-A
3
-cycloalkyl, cycloalkyl-A
3
-aryl, A
2
-cycloalkyl-A
3
-aryl, cycloalkyl-A
3
-heteroaryl, A
2
-cycloalkyl-A
3
-heteroaryl, cycloalkyl-A
3
-heterocycloalkyl, A
2
-cycloalkyl-A
3
-heterocycloalkyl, cycloalkyl-A
3
-substituted cycloalkyl, A
2
-cycloalkyl-A
3
-substituted cycloalkyl, cycloalkyl-A
3
-substituted aryl, A
2
-cycloalkyl-A
3
-substituted aryl, substituted cycloalkyl-A
3
-cycloalkyl, A
2
-substituted cycloalkyl-A
3
-cycloalkyl, substituted cycloalkyl-A
3
-substituted cycloalkyl, A
2
-substituted cycloalkyl-A
3
-substituted cycloalkyl, substituted cycloalkyl-A
3
-aryl, A
2
-substituted cycloalkyl-A
3
-aryl, substituted cycloalkyl-A
3
-heteroaryl, A
2
-substituted cycloalkyl-A
3
-heteroaryl, substituted cycloalkyl-A
3
-heterocycloalkyl, A
2
-substituted cycloalkyl-A
3
-heterocycloalkyl, substituted cycloalkyl-A
3
-substituted aryl, A
2
-substituted cycloalkyl-A
3
-substituted aryl, heteroaryl-A
3
-heteroaryl, A
2
-heteroaryl-A
3
-heteroaryl, heteroaryl-A
3
-cycloalkyl, A
2
-heteroaryl-A
3
-cycloalkyl, heteroaryl-A
3
-substituted cycloalkyl, A
2
-heteroaryl-A
3
-substituted cycloalkyl, heteroaryl-A
3
-aryl, A
2
-heteroaryl-A
3
-aryl, heteroaryl-A
3
-heterocycloalkyl, A
2
-heteroaryl-A
3
-heterocycloalkyl, heteroaryl-A
3
-substituted aryl, A
2
-heteroaryl-A
3
-substituted aryl, heterocycloalkyl-A
3
-heterocycloalkyl, A
2
-heterocycloalkyl-A
3
-heterocycloalkyl, heterocycloalkyl-A
3
-cycloalkyl, A
2
-heterocycloalkyl-A
3
-cycloalkyl, heterocycloalkyl-A
3
-substituted cycloalkyl, A
2
-heterocycloalkyl-A
3
-substituted cycloalkyl, heterocycloalkyl-A
3
-aryl, A
2
-heterocycloalkyl-A
3
-aryl, heterocycloalkyl-A
3
-substituted aryl, A
2
-heterocycloalkyl-A
3
-substituted aryl, heterocycloalkyl-A
3
-heteroaryl, A
2
-heterocycloalkyl-A
3
-heteroaryl, substituted aryl-A
3
-substituted aryl, A
2
-substituted aryl-A
3
-substituted aryl, substituted aryl-A
3
-cycloalkyl, A
2
-substituted aryl-A
3
-cycloalkyl, substituted aryl-A
3
-substituted cycloalkyl, A
2
-substituted aryl-A
3
-substituted cycloalkyl, substituted aryl-A
3
-aryl, A
2
-substituted aryl-A
3
-aryl, substituted aryl-A
3
-heteroaryl, A
2
-substituted aryl-A
3
-heteroaryl, substituted aryl-A
3
-heterocycloalkyl, and A
2
-substituted aryl-A
3
-heterocycloalkyl.
R
6
is hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, A
2
-cycloalkyl, A
2
-substituted cycloalkyl, aryl, substituted aryl, A
2
-aryl, A
2
-substituted aryl, aryl-A
3
-aryl, A
2
-aryl-A
3
-aryl, heteroaryl, A
2
-heteroaryl, heterocycloalkyl, A
2
-heterocycloalkyl, aryl-A
3
-cycloalkyl, A
2
-aryl-A
3
-cycloalkyl, aryl-A
3
-heteroaryl, A
2
-aryl-A
3
-heteroaryl, aryl-A
3
-heterocycloalkyl, A
2
-aryl-A
3
-heterocycloalkyl, carboxy, alkoxycarbonyl,
alkoxycarbonylamino, aryloxycarbonylamino, arylcarbonylamino, —N(alkyl)(alkoxycarbonyl), —N(alkyl)(aryloxycarbonyl), alkylcarbonylamino, —N(alkyl)(alkylcarbonyl), or —N(alkyl)(arylcarbonyl).
m is an integer from 1 to 5.
Y is O, S, N—R
4
, N—SO
2
—R
7
,
R
7
is alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, A
2
-cycloalkyl, A
2
-substituted cycloalkyl, aryl, substituted aryl, A
2
-aryl, A
2
-substituted aryl, heteroaryl, A
2
-heteroaryl, heterocycloalkyl, A
2
-heterocycloalkyl, aryl-A
3
-aryl, A
2
-aryl-A
3
-aryl, aryl-A
3
-cycloalkyl, A
2
-aryl-A
3
-cycloalkyl, aryl-A
3
-heteroaryl, A
2
-aryl-A
3
-heteroaryl, aryl-A
3
-heterocycloalkyl, A
2
-aryl-A
3
-heterocycloalkyl, aryl-A
3
-substituted aryl, A
2
-aryl-A
3
-substitued aryl, aryl-A
3
-substituted cycloalkyl, A
2
-aryl-A
3
-substituted cycloalkyl, cycloalkyl-A
3
-cycloalkyl, A
2
-cycloalkyl-A
3
-cycloalkyl, cycloalkyl-A
3
-aryl, A
2
-cycloalkyl-A
3
-aryl, cycloalkyl-A
3
-heteroaryl, A
2
-cycloalkyl-A
3
-heteroaryl, cycloalkyl-A
3
-heterocycloalkyl, A
2
-cycloalkyl-A
3
-heterocycloalkyl, cycloalkyl-A
3
-substituted cycloalkyl, A
2
-cycloalkyl-A
3
-substituted cycloalkyl, cycloalkyl-A
3
-substituted aryl, A
2
-cycloalkyl-A
3
-substituted aryl, substituted cycloalkyl-A
3
-cycloalkyl, A
2
-substituted cycloalkyl-A
3
-cycloalkyl, substituted cycloalkyl-A
3
-substituted cycloalkyl, A
2
-substituted cycloalkyl-A
3
-substituted cycloalkyl, substituted cycloalkyl-A
3
-aryl, A
2
-substituted cycloalkyl-A
3
-aryl, substituted cycloalkyl-A
3
-heteroaryl, A
2
-substituted cycloalkyl-A
3
-heteroaryl, substituted cycloalkyl-A
3
-heterocycloalkyl, A
2
-substituted cycloalkyl-A
3
-heterocycloalkyl, substituted cycloalkyl-A
3
-substituted aryl, A
2
-substituted cycloalkyl-A
3
-substituted aryl, heteroaryl-A
3
-heteroaryl, A
2
-heteroaryl-A
3
-heteroaryl, heteroaryl-A
3
-cycloalkyl, A
2
-heteroaryl-A
3
-cycloalkyl, heteroaryl-A
3
-substituted cycloalkyl, A
2
-heteroaryl-A
3
-substituted cycloalkyl, heteroaryl-A
3
-aryl, A
2
-heteroaryl-A
3
-aryl, heteroaryl-A
3
-heterocycloalkyl, A
2
-heteroaryl-A
3
-heterocycloalkyl, heteroaryl-A
3
-substituted aryl, A
2
-heteroaryl-A
3
-substituted aryl, heterocycloalkyl-A
3
-heterocycloalkyl, A
2
-heterocycloalkyl-A
3
-heterocycloalkyl, heterocycloalkyl-A

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Beta lactam compounds and their use as inhibitors of tryptase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Beta lactam compounds and their use as inhibitors of tryptase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta lactam compounds and their use as inhibitors of tryptase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2866274

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.